Helping organizations make better clinical development decisions

Strategic guidance when the decisions matter most.

Clinical development is filled with complex decisions, competing priorities, and uncertainties. My role is to provide an experienced, independent perspective that helps leadership teams evaluate options, challenge assumptions, align stakeholders, and move forward with confidence. Whether supporting an emerging biotechnology company or established pharmaceutical organization, I serve as a collaborative partner focused on strengthening decisions and the development program that shape its success.


Strong clinical development programs are built on strong foundations. I help teams pressure test assumptions, anticipate execution risks, and address potential problems before they affect timelines or the quality of the data. The goal is to keep programs moving while preserving the scientific signal leadership needs to make confident decisions.
— Erik Lamberth, MD, FAAP

Over a 30-year career, I have occupied many of the seats that determine whether a clinical program succeeds: Pfizer Global Program Lead, practicing physician, site Principal Investigator, and Institutional Review Board Chair. I bring together these perspectives many clinical development advisors have experienced separately. Along the way, I have contributed to the development and oversight of 20 approved products.

I help teams ask better questions, make better decisions, and turn promising science into stronger clinical development programs.

I had the pleasure of working with Erik Lamberth during our time at Pfizer. Erik is an exceptional physician-scientist who consistently brings deep clinical expertise, strategic thinking, and a collaborative approach to complex challenges. He has a unique ability to bridge science, medicine, and business considerations, helping teams make thoughtful, data-driven decisions. Beyond his technical strengths, Erik is a trusted colleague who fosters strong partnerships and always keeps patients at the center of his work.
— Julie Skinner, VP Bacterial Vaccines & Technology, Pfizer
Portrait of a middle-aged man with glasses, smiling in a professional setting.

Erik Lamberth, MD, FAAP

I had the distinct pleasure of working with Erik on a few vaccine programs during his tenure at Pfizer and he is one of the strongest clinical leads I have interacted with during my 15+ years at Pfizer. His ability to understand his programs at both the micro level (study specific details and nuances) and macro level (broader commercial/medical strategy and competitive dynamics) is a rare skill and enables him to be highly effective within the broader cross-functional teams in which he participates. Beyond the day-to-day work skills, I found Erik to be an extremely quick learner, fantastic communicator, and all around wonderful human being. I would highly recommend Erik for any endeavor in which you need a highly competent and self-motivated leader.
— Daniel Bakken, VP Commercial Development: Vaccines at Pfizer
I had the great pleasure to work with Erik Lamberth, MD for 16 plus years at Grand View Health. I hired him into the position of Chair of the IRB at Grand View several years ago and his leadership and vision for our IRB were truly transformative. I came to know Dr. Lamberth when he joined a pediatric practice across the street from Grand View and my children became his patients. He was a wonderful pediatrician in a practice that was heavily involved in research by serving as a site for studies. My children were participants in those studies and he was kind and gentle and extremely informative every step of the way. They are in their 30’s now and are still proud that they “got to help” other children along the way by helping to eradicate diseases.

When I was searching for an IRB Chair in my administrative position (and eventually the CEO position) at Grand View, Dr. Lamberth was an obvious and enthusiastic choice. He had walked the walk, meeting with parents and children and explaining and enrolling them into vaccine studies, he sat as a member of our IRB and then took on the position of chair. It wasn’t an easy job, but it became an exceptional IRB with his leadership, knowledge, and collegial spirit. He served as the Chair for 16 years when he left to start his career in the vaccine industry, leading large scale industrial vaccine programs. I have watched him achieve great success there, with a steady increase in responsibilities throughout his career, literally saving lives on a global scale.

I am very proud to call him a former colleague of mine. He knows the research and development business from all points of view and is an incredible asset to anyone in need of help and guidance along a similar journey.
— Jean Keeler, CEO Emeritus Grand View Health

Let’s get started…